老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enanta Pharmaceuticals Inc.

14.11
+0.16001.15%
盤後：14.110.00000.00%16:10 EDT
成交量：22.76萬
成交額：321.05萬
市值：4.09億
市盈率：-4.57
高：14.41
開：13.94
低：13.85
收：13.95
52周最高：17.15
52周最低：4.23
股本：2,901.85萬
流通股本：2,083.05萬
量比：2.25
換手率：1.09%
股息：- -
股息率：- -
每股收益(TTM):-3.0871
每股收益(LYR):-3.8381
淨資產收益率：-60.01%
總資產收益率：-13.47%
市淨率：3.23
市盈率(LYR):-3.68

資料載入中...

總覽公司新聞資訊公告
2020/03/04

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/02

重要事件披露

Current report, item 5.07
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/02/06

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/23

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/27

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2019/11/21

重要事件披露

Current report, items 2.02 and 9.01
2019/09/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/09

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/06

重要事件披露

Current report, items 2.02 and 9.01
2019/06/26

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/05/10

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/05/07

重要事件披露

Current report, items 2.02 and 9.01
2019/03/07

重要事件披露

[Amend] Current report, items 5.02 and 9.01
2017/05/09

重要事件披露

ENANTA製藥有限公司
更多